• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Access to mental health and substance use treatment improved with comprehensive primary care plus program

byJayden BerdugoandAlex Chan
May 4, 2024
in Chronic Disease, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a cohort of individuals, those diagnosed with an opioid use disorder (OUD), anxiety, or depression that were associated with a Comprehensive Primary Care Plus (CPC+) practice had increased utilization of mental health services and substance use treatment. 

2. Although CPC+ practices had higher utilization, the costs were not significantly different from non-CPC+ practices. 

Evidence Rating Level: 2 (Good)

Many individuals have been negatively affected by the COVID-19 pandemic, both those affected by the disease and the decline in mental health experienced secondary to lockdowns. Along with this increased struggle, there was a shortage of mental health professionals in the United States leading to more unmet therapy needs. The Comprehensive Primary Care Plus (CPC+), an advanced primary care model with behavioural integration, was used to improve the quality, access, and efficiency of primary care. To test the CPC+ model, 469 practices and a total of 102 733 patients (mean [SD] age, 49.5 [5.6] years, 57 531 women [56.4%] and 45 202 men [43.6%]) were placed into the 152 CPC+ practices, while 86 037 patients (mean [SD] age, 51.6 [6.6] years; 47 321 women [54.9%] and 38 716 men [45.1%] were attributed to 317 non-CPC+ practices. The CPC+ practices were greater in number overall while diagnosing fewer patients with chronic conditions. In patients diagnosed with an opioid use disorder (OUD), belonging to a CPC+ practice was associated with more prescriptions filled for buprenorphine (0.177 [95% CI, 0.037 to 0.196] prescriptions per patient per quarter) and anxiolytics (0.162 [95% CI, 0.005 to 0.319] prescriptions per patient per quarter). Similarly, in individuals diagnosed with anxiety or depression, those associated with a CPC+ clinic were associated with more prescriptions for buprenorphine (0.024 [95% CI, 0.006 to 0.041] prescriptions per patient per quarter). Although there were differences between health care usage in the CPC+ versus non-CPC+ clinics, there was no cost difference for patients between the practices. Overall, individuals diagnosed with an OUD that were associated with a CPC+ clinic filled more prescriptions for anxiolytics and buprenorphine compared to those at non-CPC+ clinics. 

Click to read the study in JAMA Network Open

Image: PD

RELATED REPORTS

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: family medicineprimary carepsychiatrysubstance use disorder
Previous Post

Prenatal opioid exposure not associated with increased risk of neuropsychiatric disorders in children

Next Post

Cardiovascular risk associated with social determinants of health at individual and area levels

RelatedReports

Children’s hospital visits for suicide ideation and attempts are increasing
Chronic Disease

Use of selective serotonin reuptake inhibitors guided by pharmacogenetic testing may improve treatment response in depression

May 13, 2026
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Pharma

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

May 7, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Pharma

2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options

May 4, 2026
Systematic review examines benefits and adverse effects of cannabinoid therapy
Weekly Rewinds

2 Minute Medicine Rewind May 4, 2026

May 4, 2026
Next Post
Long-term outcomes for off-pump and on-pump CABG are similar

Cardiovascular risk associated with social determinants of health at individual and area levels

Provision of medically-tailored meals linked with lower admissions and medical spending

2 Minute Medicine May 6th, 2024

#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Immunosuppression with systemic glucocorticoids close to initiation of immune checkpoint inhibitor is associated with worse survival outcomes
  • Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes
  • 2 Minute Medicine Rewind May 25, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.